Cargando…
EUROPEAN EXPERT CONSENSUS ON IMPROVING PATIENT SELECTION FOR THE MANAGEMENT OF DISABLING SPASTICITY WITH INTRATHECAL BACLOFEN AND/OR BOTULINUM TOXIN TYPE A
OBJECTIVE: To develop an algorithm for the selection of adults with disabling spasticity for treatment with intrathecal baclofen (ITB) and/or botulinum toxin type A (BoNT A). METHODS: A European Advisory Board of 4 neurologists and 4 rehabilitation specialists performed a literature review on ITB an...
Autores principales: | BIERING-SØRENSEN, Bo, STEVENSON, Valerie L., BENSMAIL, Djamel, GRABLJEVEC, Klemen, MARTÍNEZ MORENO, Mercedes, PUCKS-FAES, Elke, WISSEL, Joerg, ZAMPOLINI, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Foundation for Rehabilitation Information
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8862646/ https://www.ncbi.nlm.nih.gov/pubmed/34608495 http://dx.doi.org/10.2340/16501977-2877 |
Ejemplares similares
-
Intrathecal Baclofen in Hereditary Spastic Paraparesis
por: Pucks-Faes, Elke, et al.
Publicado: (2019) -
On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study
por: Halbmayer, Lucas‐Michael, et al.
Publicado: (2022) -
Intrathecal baclofen in paroxysmal sympathetic hyperactivity: Impact on oral treatment
por: Pucks‐Faes, Elke, et al.
Publicado: (2018) -
Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity: A Randomized Trial (SISTERS)
por: Creamer, Michael, et al.
Publicado: (2018) -
Eleven years’ experience with Intrathecal Baclofen – Complications, risk factors
por: Pucks‐Faes, Elke, et al.
Publicado: (2018)